Document is current
Any future updates will be listed below
-
Authors
Kerr, Shona M.
Klaric, Lucija https://orcid.org/0000-0003-3105-8929
Halachev, Mihail
Hayward, Caroline https://orcid.org/0000-0002-9405-9550
Boutin, Thibaud S. https://orcid.org/0000-0003-4754-1675
Meynert, Alison M.
Semple, Colin A.
Tuiskula, Annukka M. https://orcid.org/0000-0002-6538-635X
Swan, Heikki
Santoyo-Lopez, Javier
Vitart, Veronique https://orcid.org/0000-0002-4991-3797
Haley, Chris https://orcid.org/0000-0002-9811-0210
Dean, John
Miedzybrodzka, Zosia
Aitman, Timothy J.
Wilson, James F. https://orcid.org/0000-0001-5751-9178
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (MC_UU_00007/10, MC_UU_00007/10, MC/PC/15080)
Chief Scientist Office (SGP/1)
- License Information
-
More Information
Article History
Received: 6 February 2019
Accepted: 17 July 2019
First Online: 29 July 2019
Competing Interests
: T.J.A. discloses consultancy and lecture fees from AstraZeneca and Illumina. The other authors declare that they have no competing interests.
